Tornier N.V. and 4 Stocks Energizing Investors After Earnings

Tornier N.V. (NASDAQ:TRNX) had a loss and missed Wall Street’s expectations, BUT beat the revenue expectation. Adjusted Earnings Per Share increased to $-0.28 in the quarter versus EPS of $-0.13 in the year-earlier quarter. Revenue Rose 18.32% to $78.1 million from the year-earlier quarter.

Tornier N.V. reported adjusted EPS loss of $0.28 per share. By that measure, the company missed the mean analyst estimate of $-0.14. It beat the average revenue estimate of $77.2 million.

TRNX 20130811

Santarus Inc. (NASDAQ:SNTS) delivered a profit and beat Wall Street’s expectations, AND beat the revenue expectation. Adjusted Earnings Per Share increased 1780% to $0.94 in the quarter versus EPS of $0.05 in the year-earlier quarter. Revenue Rose 89.45% to $89.4 million from the year-earlier quarter.

Santarus Inc. reported adjusted EPS income of $0.94 per share. By that measure, the company beat the mean analyst estimate of $0.18. It beat the average revenue estimate of $82.9 million.

SNTS 20130811

Jazz Pharmaceuticals, Inc. (NASDAQ:JAZZ) delivered a profit and missed Wall Street’s expectations, AND came up short on beating the revenue expectation. Adjusted Earnings Per Share increased 31.19% to $1.43 in the quarter versus EPS of $1.09 in the year-earlier quarter. Revenue Rose 60.8% to $208.3 million from the year-earlier quarter.

Jazz Pharmaceuticals, Inc. reported adjusted EPS income of $1.43 per share. By that measure, the company missed the mean analyst estimate of $1.52. It missed the average revenue estimate of $208.71 million.

JAZZ 20130811

Bio-Rad Laboratories, Inc. (NYSE:BIO) delivered a profit and missed Wall Street’s expectations, AND came up short on beating the revenue expectation. Adjusted Earnings Per Share decreased 28.99% to $1.20 in the quarter versus EPS of $1.69 in the year-earlier quarter. Revenue Rose 2.86% to $525 million from the year-earlier quarter.

Bio-Rad Laboratories, Inc. reported adjusted EPS income of $1.20 per share. By that measure, the company missed the mean analyst estimate of $1.25. It missed the average revenue estimate of $532.6 million.

BIO 20130811

DaVita, Inc. (NYSE:DVA) delivered a profit and met Wall Street’s expectations, AND came up short on beating the revenue expectation. Adjusted Earnings Per Share increased 23.49% to $1.84 in the quarter versus EPS of $1.49 in the year-earlier quarter. Revenue Rose 48.81% to $2.87 billion from the year-earlier quarter.

DaVita, Inc. reported adjusted EPS income of $1.84 per share. By that measure, the company missed the mean analyst estimate of $1.84. It missed the average revenue estimate of $2.88 billion.

DVA 20130811

Stocks with improving earnings metrics are worthy of your extra attention. In fact, “E = Earnings Are Increasing Quarter-Over-Quarter” is a core component of our CHEAT SHEET investing framework for this very reason. Don’t waste another minute – click here and get our CHEAT SHEET stock picks now.

More Articles About:   , ,  

More from The Cheat Sheet